Webinar: Biodiscovery and Public Health

Monash School of Medicine is proud to host the ‘Biodiscovery and Public Health’ webinar as part of the Global Alliance of Medical Excellence (GAME) conference.

The webinar taking place on 27 July 2021 showcased:

  • Rapid evidence review
  • Medical technology: lessons from the COVID-19 pandemic
  • RNA vaccine technology
  • What are the key factors in a successful public health response

With an impressive line-up of guest speakers including:

Associate Professor Elliott is the Executive Director of the National COVID-19 Clinical Evidence Taskforce, based at Cochrane Australia at Monash Public Health and Preventive Medicine, and an infectious diseaseS physician at the Alfred Hospital. Professor Elliott developed the 'living evidence’ model, now being applied around the world in the COVID-19 response.

Professor Leder is an executive member of the Monash-led five-year RISE project that investigates the impact of improved environmental health on human health outcomes. She is an infectious diseases physician, Head of the Infectious Diseases Epidemiology Unit at Monash University, and Head of Travel Medicine and Immigrant Health Services at the Victorian Infectious DiseaseService. She is an NHMRC Senior Research Fellow and a leader and Melbourne site director of GeoSentinel – a global surveillance network for imported infections.

Dr Wassiti is an early career innovator and researcher based at Monash, with expertise in mRNA and gene therapy development. Since 2017, he has been working in applying mRNA vaccines against viral diseases and as a therapeutic vaccine for skin and breast cancer; mRNA is a modular system characterised by rapid development and a simple biomanufacturing process. When COVID-19 emerged in Australia, Dr Wassiti and his team quickly developed a vaccine candidate using a novel technology, the 'Rapid Response' that he developed at the Faculty of Pharmacy and Pharmaceutical Sciences

  • Dr. Khoa Cao

Dr Khoa has dedicated his life to solving unmet clinical needs with novel medical technology. He holds a medical degree at Monash University and a Masters in Bioengineering at Stanford University as a Fulbright Scholar. He is currently exploring the development of a novel device class within the neurotechnology space, improving access to diverse datasets in medical AI.

Interested to rewatch the session?

About Monash University

Monash University is Australia’s largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation.

With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities.

As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, we consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences.

For more news, visit Medicine, Nursing and Health Sciences or Monash University.


E: media@monash.edu